Cargando…

Validation of a noninvasive aMMP‐8 point‐of‐care diagnostic methodology in COVID‐19 patients with periodontal disease

OBJECTIVES: The aim of this study was to validate an active matrix metalloproteinase (MMP‐8) point‐of‐care diagnostic tool in COVID‐19 patients with periodontal disease. SUBJECTS, MATERIALS, AND METHODS: Seventy‐two COVID‐19‐positive and 30 COVID‐19‐negative subjects were enrolled in the study. Demo...

Descripción completa

Detalles Bibliográficos
Autores principales: Gupta, Shipra, Mohindra, Ritin, Singla, Mohita, Khera, Sagar, Kumar, Amit, Rathnayake, Nilminie, Sorsa, Timo, Pfützner, Andreas, Räisänen, Ismo T., Soni, Roop K., Kanta, Poonam, Jain, Akanksha, Gauba, Krishan, Goyal, Kapil, Singh, Mini P., Ghosh, Arnab, Kajal, Kamal, Mahajan, Varun, Suri, Vikas, Bhalla, Ashish
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9350191/
https://www.ncbi.nlm.nih.gov/pubmed/35818743
http://dx.doi.org/10.1002/cre2.589
_version_ 1784762189773537280
author Gupta, Shipra
Mohindra, Ritin
Singla, Mohita
Khera, Sagar
Kumar, Amit
Rathnayake, Nilminie
Sorsa, Timo
Pfützner, Andreas
Räisänen, Ismo T.
Soni, Roop K.
Kanta, Poonam
Jain, Akanksha
Gauba, Krishan
Goyal, Kapil
Singh, Mini P.
Ghosh, Arnab
Kajal, Kamal
Mahajan, Varun
Suri, Vikas
Bhalla, Ashish
author_facet Gupta, Shipra
Mohindra, Ritin
Singla, Mohita
Khera, Sagar
Kumar, Amit
Rathnayake, Nilminie
Sorsa, Timo
Pfützner, Andreas
Räisänen, Ismo T.
Soni, Roop K.
Kanta, Poonam
Jain, Akanksha
Gauba, Krishan
Goyal, Kapil
Singh, Mini P.
Ghosh, Arnab
Kajal, Kamal
Mahajan, Varun
Suri, Vikas
Bhalla, Ashish
author_sort Gupta, Shipra
collection PubMed
description OBJECTIVES: The aim of this study was to validate an active matrix metalloproteinase (MMP‐8) point‐of‐care diagnostic tool in COVID‐19 patients with periodontal disease. SUBJECTS, MATERIALS, AND METHODS: Seventy‐two COVID‐19‐positive and 30 COVID‐19‐negative subjects were enrolled in the study. Demographic data were recorded, periodontal examination carried out, and chairside tests run for evaluating the expression of active MMP‐8 (aMMP‐8) in the site with maximum periodontal breakdown via gingival crevicular fluid sampling as well as via a mouth rinse‐based kit for general disease activity. In COVID‐19‐positive patients, the kits were run again once the patients turned COVID‐19 negative. RESULTS: The overall (n = 102) sensitivity/specificity of the mouthrinse‐based kits to detect periodontal disease was 79.41%/36.76% and that of site‐specific kits was 64.71%/55.88% while adjusting for age, gender, and smoking status increased the sensitivity and specificity (82.35%/76.47% and 73.53%/88.24, respectively). Receiver operating characteristic (ROC) analysis for the adjusted model revealed very good area under the ROC curve 0.746–0.869 (p < .001) and 0.740–0.872 (p < .001) (the aMMP‐8 mouth rinse and site‐specific kits, respectively). No statistically significant difference was observed in the distribution of results of aMMP‐8 mouth rinse test (p = .302) and aMMP‐8 site‐specific test (p = .189) once the subjects recovered from COVID‐19. CONCLUSIONS: The findings of the present study support the aMMP‐8 point‐of‐care testing (PoCT) kits as screening tools for periodontitis in COVID‐19 patients. The overall screening accuracy can be further increased by utilizing adjunctively risk factors of periodontitis. The reported noninvasive, user‐friendly, and objective PoCT diagnostic methodology may provide a way of stratifying risk groups, deciding upon referrals, and in the institution of diligent oral hygiene regimens.
format Online
Article
Text
id pubmed-9350191
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-93501912022-08-04 Validation of a noninvasive aMMP‐8 point‐of‐care diagnostic methodology in COVID‐19 patients with periodontal disease Gupta, Shipra Mohindra, Ritin Singla, Mohita Khera, Sagar Kumar, Amit Rathnayake, Nilminie Sorsa, Timo Pfützner, Andreas Räisänen, Ismo T. Soni, Roop K. Kanta, Poonam Jain, Akanksha Gauba, Krishan Goyal, Kapil Singh, Mini P. Ghosh, Arnab Kajal, Kamal Mahajan, Varun Suri, Vikas Bhalla, Ashish Clin Exp Dent Res Original Articles OBJECTIVES: The aim of this study was to validate an active matrix metalloproteinase (MMP‐8) point‐of‐care diagnostic tool in COVID‐19 patients with periodontal disease. SUBJECTS, MATERIALS, AND METHODS: Seventy‐two COVID‐19‐positive and 30 COVID‐19‐negative subjects were enrolled in the study. Demographic data were recorded, periodontal examination carried out, and chairside tests run for evaluating the expression of active MMP‐8 (aMMP‐8) in the site with maximum periodontal breakdown via gingival crevicular fluid sampling as well as via a mouth rinse‐based kit for general disease activity. In COVID‐19‐positive patients, the kits were run again once the patients turned COVID‐19 negative. RESULTS: The overall (n = 102) sensitivity/specificity of the mouthrinse‐based kits to detect periodontal disease was 79.41%/36.76% and that of site‐specific kits was 64.71%/55.88% while adjusting for age, gender, and smoking status increased the sensitivity and specificity (82.35%/76.47% and 73.53%/88.24, respectively). Receiver operating characteristic (ROC) analysis for the adjusted model revealed very good area under the ROC curve 0.746–0.869 (p < .001) and 0.740–0.872 (p < .001) (the aMMP‐8 mouth rinse and site‐specific kits, respectively). No statistically significant difference was observed in the distribution of results of aMMP‐8 mouth rinse test (p = .302) and aMMP‐8 site‐specific test (p = .189) once the subjects recovered from COVID‐19. CONCLUSIONS: The findings of the present study support the aMMP‐8 point‐of‐care testing (PoCT) kits as screening tools for periodontitis in COVID‐19 patients. The overall screening accuracy can be further increased by utilizing adjunctively risk factors of periodontitis. The reported noninvasive, user‐friendly, and objective PoCT diagnostic methodology may provide a way of stratifying risk groups, deciding upon referrals, and in the institution of diligent oral hygiene regimens. John Wiley and Sons Inc. 2022-07-11 /pmc/articles/PMC9350191/ /pubmed/35818743 http://dx.doi.org/10.1002/cre2.589 Text en © 2022 The Authors. Clinical and Experimental Dental Research published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Gupta, Shipra
Mohindra, Ritin
Singla, Mohita
Khera, Sagar
Kumar, Amit
Rathnayake, Nilminie
Sorsa, Timo
Pfützner, Andreas
Räisänen, Ismo T.
Soni, Roop K.
Kanta, Poonam
Jain, Akanksha
Gauba, Krishan
Goyal, Kapil
Singh, Mini P.
Ghosh, Arnab
Kajal, Kamal
Mahajan, Varun
Suri, Vikas
Bhalla, Ashish
Validation of a noninvasive aMMP‐8 point‐of‐care diagnostic methodology in COVID‐19 patients with periodontal disease
title Validation of a noninvasive aMMP‐8 point‐of‐care diagnostic methodology in COVID‐19 patients with periodontal disease
title_full Validation of a noninvasive aMMP‐8 point‐of‐care diagnostic methodology in COVID‐19 patients with periodontal disease
title_fullStr Validation of a noninvasive aMMP‐8 point‐of‐care diagnostic methodology in COVID‐19 patients with periodontal disease
title_full_unstemmed Validation of a noninvasive aMMP‐8 point‐of‐care diagnostic methodology in COVID‐19 patients with periodontal disease
title_short Validation of a noninvasive aMMP‐8 point‐of‐care diagnostic methodology in COVID‐19 patients with periodontal disease
title_sort validation of a noninvasive ammp‐8 point‐of‐care diagnostic methodology in covid‐19 patients with periodontal disease
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9350191/
https://www.ncbi.nlm.nih.gov/pubmed/35818743
http://dx.doi.org/10.1002/cre2.589
work_keys_str_mv AT guptashipra validationofanoninvasiveammp8pointofcarediagnosticmethodologyincovid19patientswithperiodontaldisease
AT mohindraritin validationofanoninvasiveammp8pointofcarediagnosticmethodologyincovid19patientswithperiodontaldisease
AT singlamohita validationofanoninvasiveammp8pointofcarediagnosticmethodologyincovid19patientswithperiodontaldisease
AT kherasagar validationofanoninvasiveammp8pointofcarediagnosticmethodologyincovid19patientswithperiodontaldisease
AT kumaramit validationofanoninvasiveammp8pointofcarediagnosticmethodologyincovid19patientswithperiodontaldisease
AT rathnayakenilminie validationofanoninvasiveammp8pointofcarediagnosticmethodologyincovid19patientswithperiodontaldisease
AT sorsatimo validationofanoninvasiveammp8pointofcarediagnosticmethodologyincovid19patientswithperiodontaldisease
AT pfutznerandreas validationofanoninvasiveammp8pointofcarediagnosticmethodologyincovid19patientswithperiodontaldisease
AT raisanenismot validationofanoninvasiveammp8pointofcarediagnosticmethodologyincovid19patientswithperiodontaldisease
AT soniroopk validationofanoninvasiveammp8pointofcarediagnosticmethodologyincovid19patientswithperiodontaldisease
AT kantapoonam validationofanoninvasiveammp8pointofcarediagnosticmethodologyincovid19patientswithperiodontaldisease
AT jainakanksha validationofanoninvasiveammp8pointofcarediagnosticmethodologyincovid19patientswithperiodontaldisease
AT gaubakrishan validationofanoninvasiveammp8pointofcarediagnosticmethodologyincovid19patientswithperiodontaldisease
AT goyalkapil validationofanoninvasiveammp8pointofcarediagnosticmethodologyincovid19patientswithperiodontaldisease
AT singhminip validationofanoninvasiveammp8pointofcarediagnosticmethodologyincovid19patientswithperiodontaldisease
AT ghosharnab validationofanoninvasiveammp8pointofcarediagnosticmethodologyincovid19patientswithperiodontaldisease
AT kajalkamal validationofanoninvasiveammp8pointofcarediagnosticmethodologyincovid19patientswithperiodontaldisease
AT mahajanvarun validationofanoninvasiveammp8pointofcarediagnosticmethodologyincovid19patientswithperiodontaldisease
AT surivikas validationofanoninvasiveammp8pointofcarediagnosticmethodologyincovid19patientswithperiodontaldisease
AT bhallaashish validationofanoninvasiveammp8pointofcarediagnosticmethodologyincovid19patientswithperiodontaldisease